Azelaic acid may be the most-abandoned good ingredient in skincare. Its evidence is excellent — a first-line prescription for rosacea for decades, with controlled data for post-inflammatory pigment and comedonal acne, safe in pregnancy, no sun sensitivity — and its cosmetic reputation is terrible, because the 10 percent formulas people can buy without a prescription have tended to be gritty suspensions that pill under sunscreen, turn crunchy under makeup and sting for a fortnight. People try it, hate the texture, and stop before it has done anything. The INKEY List's 10% Azelaic Acid Serum for Redness Relief, launched in September 2022, is best understood as an engineering exercise in removing the reasons people quit, and judged that way it is one of the brand's better products.
The INKEY List, founded in Nottingham in 2018 on the idea that plain labels and honest names could make actives cheap, built this in its dermatologist-partnered 'Super Solutions' range, and the seventeen-ingredient list is unusually purposeful. Water, azelaic acid second at a declared 10 percent, propanediol, then an acrylate-taurate copolymer, acacia gum and xanthan — the gel system that suspends the acid smoothly — allantoin at a declared 0.3 percent, glycerin, a preservative pair, two emulsifiers, a starch, sodium hydroxide to bring the pH into range, two gardenia fruit extracts for a natural green tint, and polylysine. No fragrance, no oil, no silicone, no alcohol. Every ingredient is either the acid, the thing that makes the acid tolerable, or the thing that makes it wearable.
And it is wearable, which is the headline. The serum is a faintly green gel-cream that spreads thin, absorbs in a minute and dries to nothing — no grit, no crunch, no white film — and then takes sunscreen and foundation over it without the pilling that has sent so many azelaic products to the back of the drawer. The green is a colour-corrector's trick, borrowed from makeup: sheer enough to be invisible on most skin, it optically cancels pink the moment it goes on, which is why redness looks better on day one, before the azelaic acid has done any pharmacology. The first applications tingle — a warm, itchy prickle for a minute or two on reactive skin, the ingredient's known introduction — and the allantoin keeps that short; by the end of the first week most people no longer notice it.
The pharmacology follows on the ingredient's own schedule. Redness and flushing on rosacea-prone skin calm within a couple of weeks — the brand's study says four days for visible change and fourteen for its measured result, which is a brand-run figure but a plausible one for an anti-inflammatory at this dose. Post-blemish marks and mild hyperpigmentation fade over eight to twelve weeks, as azelaic acid's tyrosinase inhibition works, provided sunscreen is worn; comedones thin out over the same period. None of this is dramatic and all of it is documented for 10 percent azelaic acid, and the serum's job is to be pleasant enough that a user is still applying it in week ten. The brand-site reviews, close to five hundred at 4.3 stars, describe exactly that arc: the tingle, the calm, the marks, and — repeatedly — the relief of an azelaic product that does not pill.
The limits are the ingredient's and the format's. Ten percent is the cosmetic ceiling and a slower dose than the 15 percent prescription gels and 20 percent creams; moderate papulopustular rosacea, deep melasma or persistent acne belong in that conversation, and this serum is the maintenance or the mild-case answer. The first-week tingle, however brief, is real and is the reason to start once a day with a moisturiser over it rather than twice; a burning that persists or leads to peeling means the skin's barrier is not ready. Very fair skin can pick up a faint green from a heavy hand. The pump dispenses unevenly for some. And the four-day claim, printed on the front, is the brand's own study without a published method, and should be read as the optical green plus early calming rather than as a trial result.
Twenty dollars for 30 millilitres — two to three months over the whole face — is the same price as the gritty azelaic products it improves on and a fraction of the dermatology-brand azelaic serums that share its smooth texture; the value is unusually good because the formulation is the expensive part of an azelaic product and the acid itself is cheap. Sephora and Boots stock it, and the brand discounts it regularly.
So the recommendation is easy and slightly evangelical. For redness-prone, rosacea-prone, mark-prone or mildly breakout-prone skin — including pregnant skin, for which azelaic acid is one of the few actives left — this is the azelaic serum to try, or to try again after abandoning a worse one: a pea morning and night once the tingle has passed, a moisturiser over it, sunscreen always, and two months of patience for the marks. It does not make azelaic acid stronger; it makes it stay in the routine, and that is the whole trick.
